GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Surgical Science Sweden AB (OTCPK:SUSRF) » Definitions » 3-Year EBITDA Growth Rate

SUSRF (Surgical Science Sweden AB) 3-Year EBITDA Growth Rate : 6.40% (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Surgical Science Sweden AB 3-Year EBITDA Growth Rate?

Surgical Science Sweden AB's EBITDA per Share for the three months ended in Dec. 2024 was $0.07.

During the past 12 months, Surgical Science Sweden AB's average EBITDA Per Share Growth Rate was -23.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 6.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 31.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Surgical Science Sweden AB was 112.40% per year. The lowest was -12.50% per year. And the median was 50.00% per year.


Competitive Comparison of Surgical Science Sweden AB's 3-Year EBITDA Growth Rate

For the Health Information Services subindustry, Surgical Science Sweden AB's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surgical Science Sweden AB's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Surgical Science Sweden AB's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Surgical Science Sweden AB's 3-Year EBITDA Growth Rate falls into.


;
;

Surgical Science Sweden AB 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Surgical Science Sweden AB  (OTCPK:SUSRF) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Surgical Science Sweden AB 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Surgical Science Sweden AB's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Surgical Science Sweden AB Business Description

Traded in Other Exchanges
Address
Drakegatan 7A, Gothenburg, SWE, SE-412 50
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments; Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations, prior to entering the clinical environment and also support and services, and Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments and also simulators for medical device companies.